The anticancer effects of hispolon on lung cancer cells

Biochemical and Biophysical Research Communications

Volumn 453, Issue 3, 2014, Pages 385-391

  Wu, Qiuge ^a   Kang, Yan ^a   Zhang, Hui ^a   Wang, Hongmin ^a   Liu, Yuanhua ^a   Wang, Jing ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle arrest; Hispolon; Lung cancer; p53; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; CYTOCHROME C; HISPOLON; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHENOL DERIVATIVE; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CATECHOL DERIVATIVE;

A549 CELL LINE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; LUNG CANCER; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; PROTEIN EXPRESSION; DOSE RESPONSE; DRUG EFFECTS; LUNG TUMOR; PATHOLOGY; TUMOR CELL LINE;

PHELLINUS IGNIARIUS;

APOPTOSIS; CATECHOLS; CELL CYCLE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG NEOPLASMS;

EID: 84918594580     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.09.098     Document Type: Article

References (29)

1. S.W. Han, J. Roman, Targeting apoptotic signaling pathways in human lung cancer, Curr. Cancer Drug Targets 10 (2010) 566-574.
2. D.E. Midthun, J.R. Jett, Chemotherapy for advanced lung cancer. When to expect a response, Postgrad. Med. 101 (1997) 187-188 (191-2, 194 passim).
3. R. Salgia, T. Hensing, N. Campbell, A.K. Salama, M. Maitland, P. Hoffman, V. Villaflor, E.E. Vokes, Personalized treatment of lung cancer, Semin. Oncol. 38 (2011) 274-283.
4. L. West, S.J. Vidwans, N.P. Campbell, J. Shrager, G.R. Simon, R. Bueno, P.A. Dennis, G.A. Otterson, R. Salgia, A novel classification of lung cancer into molecular subtypes, PLoS One 7 (2012) e31906.
5. P. Toopmuang, C. Khamchum, V. Punsuvon, Detection and confirmation of hispolon in the mushroom Phellinus linteus, ScienceAsia 40 (2014) 141-144.
6. G.J. Huang, J.S. Deng, C.S. Chiu, J.C. Liao, W.T. Hsieh, M.J. Sheu, C.H. Wu, Hispolon protects against acute liver damage in the rat by inhibiting lipid peroxidation, proinflammatory cytokine, oxidative stress and down-regulating the expressions of iNOS, COX-2, and MMP-9, Evid. Based Complement. Alternat. Med. 2012 (2012) 480714.
7. H.Y. Chang, M.J. Sheu, C.H. Yang, T.C. Lu, Y.S. Chang, W.H. Peng, S.S. Huang, G.J. Huang, Analgesic effects and the mechanisms of anti-inflammation of hispolon in mice, Evid. Based Complement. Alternat. Med. 2011 (2011) 478246.
8. G.J. Huang, C.M. Yang, Y.S. Chang, S. Amagaya, H.C. Wang, W.C. Hou, S.S. Huang, M.L. Hu, Hispolon suppresses SK-Hep1 human hepatoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen activator through the PI3K/Akt and ERK signaling pathways, J. Agric. Food Chem. 58 (2010) 9468-9475.
9. G.J. Huang, J.S. Deng, S.S. Huang, M.L. Hu, Hispolon induces apoptosis and cell cycle arrest of human hepatocellular carcinoma Hep3B cells by modulating ERK phosphorylation, J. Agric. Food Chem. 59 (2011) 7104-7113.
10. W. Chen, Z. Zhao, L. Li, B. Wu, S.F. Chen, H. Zhou, Y. Wang, Y.Q. Li, Hispolon induces apoptosis in human gastric cancer cells through a ROS-mediated mitochondrial pathway, Free Radic. Biol. Med. 45 (2008) 60-72.
11. P.C. Hsiao, Y.H. Hsieh, J.M. Chow, S.F. Yang, M. Hsiao, K.T. Hua, C.H. Lin, H.Y. Chen, M.H. Chien, Hispolon induces apoptosis through JNK1/2-mediated activation of a Caspase-8, -9, and -3-dependent pathway in Acute Myeloid Leukemia (AML) cells and inhibits AML Xenograft tumor growth in vivo, J. Agric. Food Chem. 61 (2013) 10063-10073.
12. Y.C. Chen, H.Y. Chang, J.S. Deng, J.J. Chen, S.S. Huang, I.H. Lin, W.L. Kuo, W. Chao, G.J. Huang, Hispolon from Phellinus linteus induces G0/G1 cell cycle arrest and apoptosis in NB4 human leukaemia cells, Am. J. Chin. Med. 41 (2013) 1439-1457.
13. R.S. Wong, Apoptosis in cancer: from pathogenesis to treatment, J. Exp. Clin. Cancer Res. 30 (2011) 87.
14. K. Hastak, M.K. Agarwal, H. Mukhtar, M.L. Agarwal, Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate, FASEB J. 19 (2005) 789-791.
15. A.M. Abukhdeir, B.H. Park, P21 and p27: roles in carcinogenesis and drug resistance, Expert. Rev. Mol. Med. 10 (2008) e19.
16. J. Wang, F. Hu, Y. Luo, H. Luo, N. Huang, F. Cheng, Z. Deng, W. Deng, K. Zou, Estrogenic and anti-estrogenic activities of hispolon from Phellinus lonicerinus (Bond.) Bond. et sing, Fitoterapia 95 (2014) 93-101.
17. P.C. Hsiao, Y.H. Hsieh, J.M. Chow, S.F. Yang, M. Hsiao, K.T. Hua, C.H. Lin, H.Y. Chen, M.H. Chien, Hispolon induces apoptosis through JNK1/2-mediated activation of a caspase-8, -9, and -3-dependent pathway in acute myeloid leukemia (AML) cells and inhibits AML xenograft tumor growth in vivo, J. Agric. Food Chem. 61 (2013) 10063-10073.
18. J. Ravindran, G.V. Subbaraju, M.V. Ramani, B. Sung, B.B. Aggarwal, Bisdemethylcurcumin and structurally related hispolon analogues of curcumin exhibit enhanced prooxidant, anti-proliferative and anti-inflammatory activities in vitro, Biochem. Pharmacol. 79 (2010) 1658-1666.
19. W. Chen, F.Y. He, Y.Q. Li, The apoptosis effect of hispolon from Phellinus linteus (Berkeley & Curtis) Teng on human epidermoid KB cells, J. Ethnopharmacol. 105 (2006) 280-285.
20. G.J. Huang, J.S. Deng, S.S. Huang, M.L. Hu, Hispolon induces apoptosis and cell cycle arrest of human hepatocellular carcinoma Hep3B cells by modulating ERK phosphorylation, J. Agric. Food Chem. 59 (2011) 7104-7113.
21. T.L. Lu, G.J. Huang, T.J. Lu, J.B. Wu, C.H. Wu, T.C. Yang, A. Iizuka, Y.F. Chen, Hispolon from Phellinus linteus has antiproliferative effects via MDM2-recruited ERK1/2 activity in breast and bladder cancer cells, Food Chem. Toxicol. 47 (2009) 2013-2021.
22. M.T. Park, S.J. Lee, Cell cycle and cancer, J. Biochem. Mol. Biol. 36 (2003) 60-65.
23. S. Rodriguez-Nieto, B. Zhivotovsky, Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment, Curr. Pharm. Des. 12 (2006) 4411-4425.
24. K. Takeda, J. Stagg, H. Yagita, K. Okumura, M.J. Smyth, Targeting death-inducing receptors in cancer therapy, Oncogene 26 (2007) 3745-3757.
25. P. Hasty, B.A. Christy, P53 as an intervention target for cancer and aging, Pathobiol. Aging Age Relat. Dis. 3 (2013).
26. L. Li, H.J. Dai, M. Ye, S.L. Wang, X.J. Xiao, J. Zheng, H.Y. Chen, Y.H. Luo, J. Liu, Lycorine induces cell-cycle arrest in the G0/G1 phase in K562 cells via HDAC inhibition, Cancer Cell Int. 12 (2012) 49.
27. J.E. Chipuk, D.R. Green, Cytoplasmic p53: bax and forward, Cell Cycle 3 (2004) 429-431.
28. Y. Lin, J. Xu, H. Liao, L. Li, L. Pan, Piperine induces apoptosis of lung cancer A549 cells via p53-dependent mitochondrial signaling pathway, Tumour Biol. 35 (2014) 3305-3310.
29. U. Shah, N.E. Sharpless, D.N. Hayes, LKB1 and lung cancer: more than the usual suspects, Cancer Res. 68 (2008) 3562-3565.